Compagno D - Search Results

1

Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancer.

Chauchereau A, Al Nakouzi N, Gaudin C, Le Moulec S, Compagno D, Auger N, Bénard J, Opolon P, Rozet F, Validire P, Fromont G, Fizazi K. Chauchereau A, et al. Among authors: compagno d. Exp Cell Res. 2011 Feb 1;317(3):262-75. doi: 10.1016/j.yexcr.2010.10.012. Epub 2010 Oct 23. Exp Cell Res. 2011. PMID: 20974126

2

Regulation of eIF4F Translation Initiation Complex by the Peptidyl Prolyl Isomerase FKBP7 in Taxane-resistant Prostate Cancer.

Garrido MF, Martin NJ, Bertrand M, Gaudin C, Commo F, El Kalaany N, Al Nakouzi N, Fazli L, Del Nery E, Camonis J, Perez F, Lerondel S, Le Pape A, Compagno D, Gleave M, Loriot Y, Désaubry L, Vagner S, Fizazi K, Chauchereau A. Garrido MF, et al. Among authors: compagno d. Clin Cancer Res. 2019 Jan 15;25(2):710-723. doi: 10.1158/1078-0432.CCR-18-0704. Epub 2018 Oct 15. Clin Cancer Res. 2019. PMID: 30322877

3

Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancer.

Gentilini LD, Jaworski FM, Tiraboschi C, Pérez IG, Kotler ML, Chauchereau A, Laderach DJ, Compagno D. Gentilini LD, et al. Among authors: compagno d. Oncotarget. 2017 Jul 4;8(27):44654-44668. doi: 10.18632/oncotarget.17963. Oncotarget. 2017. PMID: 28591719 Free PMC article.

4

A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease.

Laderach DJ, Gentilini LD, Giribaldi L, Delgado VC, Nugnes L, Croci DO, Al Nakouzi N, Sacca P, Casas G, Mazza O, Shipp MA, Vazquez E, Chauchereau A, Kutok JL, Rodig SJ, Elola MT, Compagno D, Rabinovich GA. Laderach DJ, et al. Among authors: compagno d. Cancer Res. 2013 Jan 1;73(1):86-96. doi: 10.1158/0008-5472.CAN-12-1260. Epub 2012 Oct 29. Cancer Res. 2013. PMID: 23108139

5

Combining inhibition of galectin-3 with and before a therapeutic vaccination is critical for the prostate-tumor-free outcome.

Tiraboschi C, Gentilini L, Velazquez C, Corapi E, Jaworski FM, Garcia Garcia JD, Rondón Y, Chauchereau A, Laderach DJ, Compagno D. Tiraboschi C, et al. Among authors: compagno d. J Immunother Cancer. 2020 Dec;8(2):e001535. doi: 10.1136/jitc-2020-001535. J Immunother Cancer. 2020. PMID: 33293356 Free PMC article.

6

SIRNA-directed in vivo silencing of androgen receptor inhibits the growth of castration-resistant prostate carcinomas.

Compagno D, Merle C, Morin A, Gilbert C, Mathieu JR, Bozec A, Mauduit C, Benahmed M, Cabon F. Compagno D, et al. PLoS One. 2007 Oct 10;2(10):e1006. doi: 10.1371/journal.pone.0001006. PLoS One. 2007. PMID: 17925854 Free PMC article.

7

RGS16 is a negative regulator of SDF-1-CXCR4 signaling in megakaryocytes.

Berthebaud M, Rivière C, Jarrier P, Foudi A, Zhang Y, Compagno D, Galy A, Vainchenker W, Louache F. Berthebaud M, et al. Among authors: compagno d. Blood. 2005 Nov 1;106(9):2962-8. doi: 10.1182/blood-2005-02-0526. Epub 2005 Jul 5. Blood. 2005. PMID: 15998835 Free article.

8

A partial down-regulation of WASP is sufficient to inhibit podosome formation in dendritic cells.

Olivier A, Jeanson-Leh L, Bouma G, Compagno D, Blondeau J, Seye K, Charrier S, Burns S, Thrasher AJ, Danos O, Vainchenker W, Galy A. Olivier A, et al. Among authors: compagno d. Mol Ther. 2006 Apr;13(4):729-37. doi: 10.1016/j.ymthe.2005.11.003. Epub 2005 Dec 15. Mol Ther. 2006. PMID: 16360341 Free article.

9

RNA interference shows critical requirement for NF-kappa B p50 in the production of IL-12 by human dendritic cells.

Laderach D, Compagno D, Danos O, Vainchenker W, Galy A. Laderach D, et al. Among authors: compagno d. J Immunol. 2003 Aug 15;171(4):1750-7. doi: 10.4049/jimmunol.171.4.1750. J Immunol. 2003. PMID: 12902474

10

In Vivo Hemin Conditioning Targets the Vascular and Immunologic Compartments and Restrains Prostate Tumor Development.

Jaworski FM, Gentilini LD, Gueron G, Meiss RP, Ortiz EG, Berguer PM, Ahmed A, Navone N, Rabinovich GA, Compagno D, Laderach DJ, Vazquez ES. Jaworski FM, et al. Among authors: compagno d. Clin Cancer Res. 2017 Sep 1;23(17):5135-5148. doi: 10.1158/1078-0432.CCR-17-0112. Epub 2017 May 16. Clin Cancer Res. 2017. PMID: 28512172

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32 results

Search Page